Macrophage reporter cell assay for screening immunopharmacological activity of cell wall-active antifungals

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 3, 2014, Pages 1738-1743

  Lewis, Russell E ^a,d   Liao, Guangling ^a   Young, Katherine ^b   Douglas, Cameron ^b   Kontoyiannis, Dimitrios P ^c  

^a UNIVERSITY OF HOUSTON   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; BETA GLUCAN; CASPOFUNGIN; CHITIN; CHITIN SYNTHASE; ENFUMAFUNGIN A; FLUCONAZOLE; GLUCAN; GLUCAN SYNTHASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NIKKOMYCIN Z; TETRACYCLINE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; VORICONAZOLE;

ARTICLE; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; DRUG SCREENING; FUNGUS GROWTH; GENE EXPRESSION; INFLAMMATION; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ALKALINE PHOSPHATASE; AMINOGLYCOSIDES; ANIMALS; ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; CANDIDA ALBICANS; CELL WALL; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHINOCANDINS; GLYCOSIDES; MACROPHAGES; MICE; MICROBIAL SENSITIVITY TESTS; NF-KAPPA B; TRANSCRIPTION FACTOR AP-1; TRITERPENES;

EID: 84896806813     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02408-13     Document Type: Article

References (30)

1. Sau K, Mambula SS, Latz E, Henneke P, Golenbock DT, Levitz SM. 2003. The antifungal drug amphotericinBpromotes inflammatory cytokine release by a toll-like receptor- and CD14-dependent mechanism. J. Biol. Chem. 278: 37561-37568. http://dx.doi.org/10.1074/jbc.M306137200. (Pubitemid 37175278)
2. Rogers PD, Jenkins JK, Chapman SW, Ndebele K, Chapman BA, Cleary JD. 1998. Amphotericin B activation of human genes encoding for cytokines. J. Infect. Dis. 178:1726-1733. http://dx.doi.org/10.1086/314495. (Pubitemid 28558146)
3. Wheeler RT, Fink GR. 2006. A drug-sensitive genetic network masks fungi from the immune system. PLoS Pathog. 2:e35. http://dx.doi.org/10.1371/journal. ppat.0020035.
4. Hohl TM, Feldmesser M, Perlin DS, Pamer EG. 2008. Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal - glucan exposure. J. Infect. Dis. 198:176-185. http://dx.doi.org/10. 1086/589304. (Pubitemid 352019282)
5. Wheeler RT, Kombe D, Agarwala SD, Fink GR. 2008. Dynamic, morphotype-specific Candida albicans β-glucan exposure during infection and drug treatment. PLoS Pathog. 4:e1000227. http://dx.doi.org/10.1371/journal. ppat.1000227.
6. Ben-Ami R, Garcia-Effron R, Lewis RE, Gamarra S, Leventakos K, Perlin DS, Kontoyiannis DP. 2011. Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance. J. Infect. Dis. 204:626-635. http://dx.doi.org/10.1093/infdis/jir351.
7. Lewis RE, Viale P, Kontoyiannis DP. 2012. The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida. Virulence 3:368-376. http://dx.doi.org/10.4161/viru.20746.
8. Clinical and Laboratory Standards Institute. 2008. Reference method for both dilution susceptibility testing of filamentous fungi, 2nd ed, M38-A2. Clinical and Laboratory Standards Institute, Wayne, PA.
9. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution of antifungal susceptibility testing of yeasts; approved standard, 3rd ed, M27-A3. Clinical and Laboratory Standards Institute, Wayne, PA.
10. Roemer TB, Jiang J, Davison J, Ketela T, Veillette K, Breton A, Tandia F, Linteau A, Sillaots S, Marta C, Martel N, Veronneau S, Lemieux S, Kauffman S, Becker J, Storms R, Boone C, Bussey H. 2003. Large-scale essential gene identification in Candida albicans and applications to antifungal drug discovery. Mol. Microbiol. 50:167-181. http://dx.doi.org/10.1046/j.1365-2958. 2003.03697.x. (Pubitemid 37222795)
11. Hu W, Sillaots S, Lemieux S, Davison J, Kauffman S, Breton A, Linteau A, Xin C, Bowman J, Becker J, Jiang B, Roemer T. 2007. Essential gene identification and drug target prioritization in Aspergillus fumigatus. PLoS Pathog. 3:e24. http://dx.doi.org/10.1371/journal.ppat.0030024.
12. Cove D. 1966. The induction and repression of nitrate reductase in the fungus Aspergillus nidulans. Biochim. Biophys. Acta 113:51-56. http://dx.doi.org/10.1016/S0926-6593(66)80120-0.
13. Brown GD. 2006. Dectin-1: a signaling non-TLR pattern-recognition receptor. Nat. Rev. Immunol. 6:33-43. http://dx.doi.org/10.1038/nri1745. (Pubitemid 43279751)
14. Bowman JC, Hicks PS, Kurtz MB, Rosen H, Schmatz DM, Liberator PA, Douglas CM. 2002. The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro. Antimicrob. Agents Chemother. 46:3001-3012. http://dx.doi.org/10.1128/AAC.46.9.3001-3012.2002.
15. Drusano GL. 2004. Antimicrobial pharmacodynamics: critical interactions of "bug and drug". Nat. Rev. Microbiol. 2:289-300. http://dx.doi.org/10.1038/nrmicro862. (Pubitemid 39490099)
16. Ben-Ami R, Lewis RE, Kontoyiannis DP. 2008. Immunocompromised hosts: immunopharmacology of modern antifungals. Clin. Infect. Dis. 47:226-235. http://dx.doi.org/10.1086/589290. (Pubitemid 351952889)
17. Ibrahim AS, Gebremariam T, Fu Y, Edwards JS, Spellberg B. 2008. Combination echinocandin-polyene treatment of murine mucormycosis. Antimicrob. Agents Chemother. 52:1556-1558. http://dx.doi.org/10.1128/AAC.01458-07. (Pubitemid 351522035)
18. Ibrahim AS, Bowman JC, Avanessian V, Brown K, Spellberg B, Edwards JE, Douglas CM. 2005. Caspofungin inhibits Rhizopus oryzae 1,3-β-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis. Antimicrob. Agents Chemother. 49:721-727. http://dx.doi.org/10.1128/AAC.49.2. 721-727.2005. (Pubitemid 40175685)
19. Lewis RE, Leventakos K, Liao G, Kontoyiannis DP. 2011. Efficacy of caspofungin in neutropenic and corticosteroid-immunosuppressed murine models of invasive pulmonary mucormycosis. Antimicrob. Agents Chemother. 55:3584-3587. http://dx.doi.org/10.1128/AAC.01812-10.
20. Spellberg B, Schwartz J, Fu Y, Avanesian V, Adler-Moore J, Edwards JE, Ibrahim AS. 2006. Comparison of antifungal treatments for murine fusariosis. J. Antimicrob. Chemother. 58:973-979. http://dx.doi.org/10.1093/jac/dkl378.
21. Bocanegra R, Najvar LK, Hernandez S, McCarthy DI, Graybill JR. 2005. Caspofungin and liposomal amphotericin B therapy of experimental murine scedosporiosis. Antimicrob. Agents Chemother. 49:5139-5141. http://dx.doi.org/ 10.1128/AAC.49.12.5139-5141.2005. (Pubitemid 41778935)
22. Mora-Montes HM, Netea MG, Ferwerda G, Lenardon MD, Brown GD, Mistry AR, Kullberg BJ, O'Callaghan CA, Sheth CC, Odds FC, Brown AJP, Munro CA, Gow NAR. 2011. Recognition and blocking of innate immunity cells by Candida albicans chitin. Infect. Immun. 79:1961-1970. http://dx.doi.org/10.1128/IAI.01282-10.
23. Walker LA, Gow NAR, Munro CA. 2013. Elevated chitin content reduces the susceptibility of Candida species to caspofungin. Antimicrob. Agents Chemother. 57:146-154. http://dx.doi.org/10.1128/AAC.01486-12.
24. Marakalala MJ, Vautier S, Potrykus J, Walker LA, Shepardson KM, Hopke A, Mora-Montes HM, Kerrigan A, Netea MG, Murray GI, MacCallum DM, Wheeler R, Munro CA, Gow NA, Cramer RA, Brown AJ, Brown GD. 2013. Differential adaptation of Candida albicans in vivo modulates immune recognition by dectin-1. PLoS Pathog. 9:e1003315. http://dx.doi.org/10.1371/journal.ppat.1003315.
25. Stone JA, Xu X, Winchell GA, Deutsch PJ, Pearson PG, Migoya EM, Mistry GC, Xi L, Miller A, Sandhu P. 2004. Disposition of caspofungin: role of distribution in determining pharmacokinetics in plasma. Antimicrob. Agents Chemother. 48:815-823. http://dx.doi.org/10.1128/AAC.48.3.815-823.2004. (Pubitemid 38280330)
26. Aly AH, Debbab A, Proksch P. 2011. Fungal endophytes: unique plant inhabitants with great promises. Appl. Microbiol. Biotechnol. 90:1829-1845. http://dx.doi.org/10.1007/s00253-011-3270-y.
27. Gaughran JP, Lai MH, Kirsch DR, Silverman SJ. 1994. Nikkomycin Z is a specific inhibitor of Saccharomyces cerevisiae chitin synthase isozyme Chs3 in vitro and in vivo. J. Bacteriol. 176:5857-5860. (Pubitemid 24280523)
28. Kruppa M, Greene RR, Noss I, Lowman DW, Williams DL. 2011. C. albicans increases cell wall mannoprotein, but not mannan, in response to blood, serum and cultivation at physiological temperature. Glycobiology 21:1173-1180. http://dx.doi.org/10.1093/glycob/cwr051.
29. Clavaud C, Beauvais A, Barbin L, Munier-Lehmann H, Latge JP. 2012. The composition of the culture medium influences the β-1,3-glucan metabolism of Aspergillus fumigatus and the antifungal activity of inhibitors of β-1,3-glucan synthesis. Antimicrob. Agents Chemother. 56: 3428-3431. http://dx.doi.org/10.1128/AAC.05661-11.
30. Lewis RE, Liao G, Hou J, Prince RA, Kontoyiannis DP. 2011. Comparative in vivo dose-dependent activity of caspofungin and anidulafungin against echinocandin-susceptible and -resistant Aspergillus fumigatus. J. Antimicrob. Chemother. 66:1324-1331. http://dx.doi.org/10.1093/jac/dkr142.